سعر الفانوفا 0.15% محلول معقم للعين 5 مل 2024

Egyptian brimonidine tartrate 0.15% (1.5 mg/ml) sterile eye drops (5 ml) by Orchidia, used to lower raised intraocular pressure.

• Lowering elevated intraocular pressure in chronic open-angle glaucoma or ocular hypertension, as monotherapy or adjunctive therapy with topical beta-blockersOrchidia Pharmaceutical Industries
• Reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertensionPopulation: Patients with open-angle glaucoma or ocular hypertension; contraindicated under 2 years (US label)DailyMed (NLM)

• Most common (10-20%): allergic conjunctivitis, conjunctival hyperemia and eye pruritus.International label, equivalent formulation · DailyMed (NLM)
• 5-9%: burning sensation, conjunctival folliculosis, hypertension, ocular allergic reaction, oral dryness and visual disturbance.International label, equivalent formulation · DailyMed (NLM)

• Neonates and infants under 2 years of age.International label, equivalent formulation · DailyMed (NLM)
• Hypersensitivity to any component of the product.International label, equivalent formulation · DailyMed (NLM)

• May potentiate syndromes associated with vascular insufficiency: use with caution in depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension or thromboangiitis obliterans.International label, equivalent formulation · DailyMed (NLM)
• Use with caution in patients with severe cardiovascular disease.International label, equivalent formulation · DailyMed (NLM)
• Multiple-dose containers can become contaminated and cause bacterial keratitis; avoid touching the tip to the eye or any surface.International label, equivalent formulation · DailyMed (NLM)

• Antihypertensives / cardiac glycosidesPossible additive blood-pressure lowering; use with caution.DailyMed (NLM)
• CNS depressants (alcohol, barbiturates, opiates, sedatives, anesthetics)Possible additive or potentiating CNS depressant effect.DailyMed (NLM)
• Tricyclic antidepressantsCaution: tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine; whether they interfere with the IOP-lowering effect of brimonidine is unknown.DailyMed (NLM)

• No adequate and well-controlled studies in pregnant women; use during pregnancy only if the potential benefit justifies the potential risk to the fetus.International label, equivalent formulation · DailyMed (NLM)
• Not recommended during breastfeeding (brimonidine may cause CNS depression/apnea in infants).International label, equivalent formulation · DailyMed (NLM)

• Brimonidine: Alpha-2 adrenergic agonist that lowers intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow (US Alphagan P label).